Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Thrombopoietin Receptor Agonists [MoA]

Known as: Thrombopoietin Receptor Agonists 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • L. Loffredo, F. Violi
  • Digestive and liver disease : official journal of…
  • 2019
  • Corpus ID: 49613989
BACKGROUND Treatment of thrombocytopenia with thrombopoietin receptor agonists (TPORAs) seems to be associated with portal vein… Expand
Review
2017
Review
2017
Since its discovery, the thrombopoietin (TPO) pathway has been an important pharmaceutical target for the treatment of… Expand
  • table 2
  • table 3
Review
2016
Review
2016
  • S. Nomura
  • Clinical medicine insights. Blood disorders
  • 2016
  • Corpus ID: 14735203
Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated clearance of platelets caused… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
2016
2016
Very few data exist on the management of adult patients diagnosed with primary immune thrombocytopenia (ITP). The objectives of… Expand
  • table 1
  • table 3
  • table 4
  • table 5
2015
2015
Background: The aim of this study was to evaluate the treatment reality for outpatients with immune thrombocytopenia (ITP… Expand
  • table 1
  • figure 1
Review
2015
Review
2015
Most children with immune thrombocytopenia (ITP) will have spontaneous remission regardless of therapy, while about 20% will go… Expand
  • figure 1
  • table 1
Highly Cited
2013
Highly Cited
2013
Thrombopoietin receptor agonists (TRAs) are effective treatments for immune thrombocytopenia (ITP). However, continuous therapy… Expand
Highly Cited
2013
Highly Cited
2013
Thrombopoietin receptor agonists (TPOra) are the only treatments for immune thrombocytopenia (ITP) for which evidence of efficacy… Expand
Review
2013
Review
2013
Introduction: Primary immune thrombocytopenia (ITP) is a minor disease for many patients; however, the natural history is… Expand
2011
2011
Aim: Thrombopoietin receptor agonists (Tpo increase platelet counts in the majority of chronic autoimmune thrombocytopenia… Expand
  • table 1
  • table 2
  • figure 2